Corticotropin-releasing hormone (CRH) receptors in the mesenteric small arteries of rats resemble the (2)-subtype

Biochemical Pharmacology

Volumn 52, Issue 6, 1996, Pages 829-833

  Rohde, Elvira ^a   Furkert, Jens ^a   Fechner, Klaus ^a   Beyermann, Michael ^a   Mulvany, Michael J ^b   Richter, Regina M ^a   Denef, Carl ^c   Bienert, Michael ^a   Berger, Hartmut ^a  

^a LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

arteries; CRH agonists; CRH antagonist; pituitary; rat; receptor

Indexed keywords

BETA ENDORPHIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR DERIVATIVE; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; CORTICOTROPIN RELEASING FACTOR[9-41]; IODINE 125; RECEPTOR SUBTYPE; SAUVAGINE; UNCLASSIFIED DRUG; UROTENSIN I;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN MEMBRANE; CONTROLLED STUDY; DRUG POTENCY; HORMONE RELEASE; HYPOPHYSIS CELL; HYPOTENSION; MALE; MESENTERIC ARTERY; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SMOOTH MUSCLE RELAXATION; VASCULAR SMOOTH MUSCLE;

EID: 0030603975     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(96)00300-0     Document Type: Article

References (22)

1. 1. Grigoriadis DE, Heroux JA and De Souza EB, Characterization and regulation of corticotropin-releasing factor receptors in the central nervous, endocrine and immune system. In: Corticotropin-Releasing Factor (Eds. Chadwick DJ, Marsh J and Ackrill K), Ciba Foundation Symposium 172, pp. 85-107. John Wiley & Sons, West Sussex, England, 1993.
2. 2. Lederis K, Letter A, McMaster D, Ichikawa T, MacCannell KL, Kobayashi Y, Rivier J, Rivier C, Vale W and Fryer J, Isolation, analysis of structure, synthesis, and biological actions of urotensin I neuropeptides. Can J Biochem Cell Biol 61: 602-614, 1983.
3. 3. Rivier C, Rivier J, Lederis K and Vale W, In vitro and in vivo ACTH-releasing activity of ovine CRF, sauvagine and urotensin I. Regul Pept 5: 139-143, 1983.
4. 4. Corder R, Turnill D, Ling N and Gaillard RC, Attenuation of corticotropin releasing factor-induced hypotension in anesthetized rats with the CRF antagonist, α-helical CRF9-41; comparison with effect on ACTH release. Peptides 13: 1-6, 1992.
5. 5. Fisher L, Rivier C, Rivier J and Brown M, Differential antagonist activity of α-helical corticotropin-releasing factor 9-41 in three bioassay systems. Endocrinology 129: 1312-1316, 1991.
6. 6. Lovenberg TW, Liaw CW, Grigoriadis DE, Clevenger W, Chalmers DT, De Souza EB and Oltersdorf T, Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 92: 836-840, 1995.
7. 7. Chang C-P, Pearse II RV, O'Connell S and Rosenfeld MG, Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron 11: 1187-1195, 1993.
8. 8. Chen R, Lewis KA, Perrin MH and Vale WW, Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci USA 90: 8967-8971, 1993.
9. 9. Perrin MH, Donaldson CJ, Chen R, Lewis KA and Vale WW, Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology 133: 3058-3061, 1993.
10. 10. Stenzel P, Kesterson R, Yeung W, Cone RD, Rittenberg MB and Stenzel-Poore MP, Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart. Molec Endocrinol 9: 637-645, 1995.
11. 11. Kishimoto T, Pearse II RV, Lin CR and Rosenfeld MG, A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc Natl Acad Sci USA 92: 1108-1112, 1995.
12. t)-containing peptides. J Chem Soc Chem Commun 853-854, 1994.
13. 13. Bradford MM, A rapid and sensitive method for the quantitation of microgram quantities of protein utelizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
14. 14. Denef C, Maertens P, Alberts W, Mignon A, Robberecht W, Swennen L and Carmeliet P, Cell-to-cell communication in peptide target cells of anterior pituitary. Methods Enzymol 168: 47-71, 1989.
15. 15. Mulvany MJ and Halpern W, Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 41: 19-26, 1977.
16. 16. Vale W, Spiess J, Rivier C and Rivier J, Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science 213: 1394-1397, 1981.
17. 17. Richter RM and Mulvany MJ, Comparison of hCRF and oCRF effects on cardiovascular responses after central, peripheral and in vitro application. Peptides 16: 843-849, 1995.
18. 18. Sutton SW, Behan DP, Lahrichi SL, Kaiser R, Corrigan A, Lowry P, Potter E, Perrin MH, Rivier J and Vale WW, Ligand requirements of the human corticotropin-releasing factor-binding protein. Endocrinology 136: 1097-1102, 1995.
19. 19. Vita N, Laurent P, Lefort S, Chalon P, Lelias J-M, Kaghad M, Le Fur G, Caput D and Ferrara P, Primary structure and functional expression of mouse pituitary and human brain corticotropin releasing factor receptors. FEBS Lett 335: 1-5, 1993.
20. 20. Lei S, Richter R, Bienert M and Mulvany MJ, Relaxing actions of corticotropin-releasing factor on rat resistance arteries. Br J Pharmacol 108: 941-947, 1993.
21. 21. Lovenberg TW, Chalmers DT, Liu CG, Desouza EB, CRF(2 alpha) and CRF(2 beta) receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology 136: 4139-4142, 1995.
22. 22. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, Rivier J, Sawchenko PE and Vale W, Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378: 287-292, 1995.